Regulus Therapeutics Inc. (NASDAQ: RGLS) Stock Information | RedChip

Regulus Therapeutics Inc. (NASDAQ: RGLS) Listen to this Section


$1.60
+0.0100 ( +0.63% ) 139.7K

Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.

Market Data


Open


$1.60

Previous close


$1.59

Volume


139.7K

Market cap


$105.40M

Day range


$1.56 - $1.64

52 week range


$1.08 - $3.79

Insider Ownership Transactions

Total Amount Purchased: -2,396,250.00 | $ -3,834,000.00

Date Type Amount Purchased Purchaser
2023-08-14 Sale -15000.00 Witz Pascale
2023-08-14 Sale -15000.00 Rosen Hugh
2023-08-14 Sale -15000.00 PAPADOPOULOS STELIOS
2023-08-14 Sale -15000.00 Nunn Jason Raleigh
2023-08-14 Sale -225000.00 Klassen Preston
2023-08-14 Sale -15000.00 Huang Alice Shih-hou
2023-08-14 Sale -375000.00 CALSADA CRISPINA
2023-08-14 Sale -1312500.00 Hagan Joseph P
2023-08-14 Sale -15000.00 BALTIMORE DAVID
2023-08-14 Sale -393750.00 Aker Christopher Ray

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Mar 21, 2024
4 Insider transactions 1 Mar 15, 2024
8-k 8K-related 21 Mar 14, 2024
4 Insider transactions 1 Jan 18, 2024
4 Insider transactions 1 Jan 18, 2024
4 Insider transactions 1 Jan 18, 2024
4 Insider transactions 1 Jan 17, 2024
4 Insider transactions 1 Jan 17, 2024
4 Insider transactions 1 Jan 17, 2024
4 Insider transactions 1 Jan 17, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.